Gastric carcinoma
MONDO:0004950A carcinoma that arises from epithelial cells of the stomach.
Also known as: cancer of stomach, cancer of the stomach, gastric (stomach) cancer, gastric cancer, gastric cancer, NOS, stomach cancer, carcinoma of stomach, carcinoma of the stomach
3389 clinical trials for this condition and its sub-types, 92 tagged with Gastric carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Gastric carcinoma
-
Gastric adenocarcinoma 449 trials · 481 incl. sub-types
9 sub-types
- Microinvasive gastric cancer 28 trials
- Diffuse gastric adenocarcinoma 1 trial · 5 incl. sub-types Sub-types →
- Gastric cardia adenocarcinoma 4 trials
- Signet ring cell gastric adenocarcinoma 2 trials
- CTNNA1-related diffuse gastric and lobular breast cancer syndrome 0 trials
- Gastric intestinal type adenocarcinoma 0 trials
- Gastric papillary adenocarcinoma 0 trials
- Gastric tubular adenocarcinoma 0 trials
- Mucinous gastric adenocarcinoma 0 trials
-
Gastric cardia carcinoma 3 trials · 7 incl. sub-types
2 sub-types
- Gastric cardia adenocarcinoma 4 trials
- Carcinoma in situ of gastric cardia 0 trials
-
Hereditary gastric cancer 1 trial · 6 incl. sub-types
-
Gastric squamous cell carcinoma 4 trials
1 sub-type
- Gastric adenosquamous carcinoma 0 trials
-
Stomach carcinoma in situ 4 trials
3 sub-types
- Carcinoma in situ of fundus of stomach 0 trials
- Carcinoma in situ of gastric body 0 trials
- Carcinoma in situ of gastric cardia 0 trials
-
Gastric body carcinoma 1 trial
1 sub-type
- Carcinoma in situ of gastric body 0 trials
-
Gastric fundus carcinoma 0 trials
1 sub-type
-
Gastric pylorus carcinoma 0 trials
Most studied deeper sub-types
-
Stomach cancer combo study halted early
Disease control Stopped earlyThis study tested several drug combinations in 40 people with advanced stomach or gastroesophageal junction cancer that had not been treated before. The goal was to see which combinations shrank tumors. The study was terminated early, so results are limited.
Phase 1/2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Cancer drug trial halted early – what happened?
Disease control Stopped earlyThis phase 2 trial tested the drug futibatinib in 115 people with advanced solid tumors or blood cancers that have specific FGFR gene changes. The goal was to see if the drug could shrink tumors or cause remission. The study was terminated early, so final results are not yet clea…
Phase 2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New pill targets Hard-to-Treat cancers in early human test
Disease control Stopped earlyThis early-phase trial tested an experimental oral drug called NKT3447 in 23 adults with advanced or metastatic solid tumors that had stopped responding to standard treatments. The goal was to check safety, find the right dose, and see if the drug could shrink tumors. The study w…
Phase 1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can a simple ear massage help cancer patients eat better?
Symptom relief Stopped earlyThis small pilot study tested whether applying acupressure to the ear could help improve appetite and prevent weight loss in people with advanced stomach, esophagus, or pancreatic cancer. The approach uses small adhesive pellets placed on specific ear spots to stimulate the nervo…
Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC